Search

Search Results
Results 171 - 180 of 968 for allergy
  • Sifrol ER
    Drug - 28 Sep 2018
    Consumer Medicine Information (CMI) about Sifrol ER (pramipexole dihydrochloride monohydrate) intended for persons living in Australia.
  • Amaryl
    Drug - 29 Aug 2016
    Consumer Medicine Information (CMI) about Amaryl (glimepiride) intended for persons living in Australia.
  • Stelara
    Drug - 15 Apr 2025
    Consumer Medicine Information (CMI) about Stelara intended for persons living in Australia.
  • Enlafax XR
    Drug - 7 Feb 2025
    Consumer Medicine Information (CMI) about Enlafax XR intended for persons living in Australia.
  • Xolair
    Drug - 26 Sep 2024
    Consumer Medicine Information (CMI) about Xolair intended for persons living in Australia.
  • Fynod
    Drug - 7 Jun 2024
    Consumer Medicine Information (CMI) about Fynod intended for persons living in Australia.
  • DBL Diazoxide
    Drug - 3 May 2024
    Consumer Medicine Information (CMI) about DBL Diazoxide (Diazoxide) intended for persons living in Australia.
  • Efexor XR
    Drug - 5 Apr 2024
    Consumer Medicine Information (CMI) about Efexor XR intended for persons living in Australia.
  • Cadivast
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cadivast intended for persons living in Australia.
  • Rixubis
    Drug - 23 Dec 2022
    Consumer Medicine Information (CMI) about Rixubis (nonacog gamma , 250, 500, 1000, 2000, 3000 IU /vial) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback